Diadema Partners »

Insmed shares owned by Diadema Partners

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.2M 53k 174.04

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Insmed

Jpmorgan Chase & Co
Vanguard Group
Darwin Global Management
BlackRock
FMR
Baker Bros. Advisors
D. E. Shaw & Co
State Street Corporation
Capital Research and Management Company - Division 3
Artisan Partners Limited Partnership
Rtw Investments
Geode Capital Management
Orbis Allan Gray
Norges Bank Investment Management
Franklin Resources

View all funds holding Insmed